Works matching IS 20445385 AND DT 2022 AND VI 12 AND IP 9

Results: 17
    1

    Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00736-z
    By:
    • Rapaport, Franck;
    • Seier, Kenneth;
    • Neelamraju, Yaseswini;
    • Hassane, Duane;
    • Baslan, Timour;
    • Gildea, Daniel T.;
    • Haddox, Samuel;
    • Lee, Tak;
    • Murdock, H. Moses;
    • Sheridan, Caroline;
    • Thurmond, Alexis;
    • Wang, Ling;
    • Carroll, Martin;
    • Cripe, Larry D.;
    • Fernandez, Hugo;
    • Mason, Christopher E.;
    • Paietta, Elisabeth;
    • Roboz, Gail J.;
    • Sun, Zhuoxin;
    • Tallman, Martin S.
    Publication type:
    Article
    2
    3

    Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00734-1
    By:
    • Duchmann, Matthieu;
    • Joudinaud, Romane;
    • Boudry, Augustin;
    • Pasanisi, Justine;
    • Di Feo, Giuseppe;
    • Kim, Rathana;
    • Bucci, Maxime;
    • Chauvel, Clémentine;
    • Chat, Laureen;
    • Larcher, Lise;
    • Pacchiardi, Kim;
    • Mathis, Stéphanie;
    • Raffoux, Emmanuel;
    • Adès, Lionel;
    • Berthon, Céline;
    • Clappier, Emmanuelle;
    • Roumier, Christophe;
    • Puissant, Alexandre;
    • Preudhomme, Claude;
    • Duployez, Nicolas
    Publication type:
    Article
    4
    5

    Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00732-3
    By:
    • Long, Thorir Einarsson;
    • Indridason, Olafur Skuli;
    • Palsson, Runolfur;
    • Rognvaldsson, Sæmundur;
    • Love, Thorvardur Jon;
    • Thorsteinsdottir, Sigrun;
    • Sverrisdottir, Ingigerdur Solveig;
    • Vidarsson, Brynjar;
    • Onundarson, Pall Torfi;
    • Agnarsson, Bjarni Agnar;
    • Sigurdardottir, Margret;
    • Thorsteinsdottir, Ingunn;
    • Olafsson, Isleifur;
    • Thordardottir, Asdis Rosa;
    • Eythorsson, Elias;
    • Jonsson, Asbjorn;
    • Gislason, Gauti;
    • Olafsson, Andri;
    • Steingrimsdottir, Hlif;
    • Hultcrantz, Malin
    Publication type:
    Article
    6
    7
    8

    Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00729-y
    By:
    • Raj, Kavita;
    • Eikema, Dirk-Jan;
    • Sheth, Vipul;
    • Koster, Linda;
    • de Wreede, Liesbeth C.;
    • Blaise, Didier;
    • Di Grazia, Carmela;
    • Koc, Yener;
    • Potter, Victoria;
    • Chevallier, Patrice;
    • Lopez- Corral, Lucia;
    • Wu, Depei;
    • Mielke, Stephan;
    • Maertens, Johan;
    • Meijer, Ellen;
    • Huynh, Anne;
    • Passweg, Jakob;
    • Luft, Thomas;
    • Pérez-Simón, Jose Antonio;
    • Ciceri, Fabio
    Publication type:
    Article
    9
    10
    11

    Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00724-3
    By:
    • Gurnari, Carmelo;
    • Piciocchi, Alfonso;
    • Soddu, Stefano;
    • Bonanni, Fabrizio;
    • Scalzulli, Emilia;
    • Niscola, Pasquale;
    • Di Veroli, Ambra;
    • Piccioni, Anna Lina;
    • Piedimonte, Monica;
    • Maiorana, Gianluca;
    • Salutari, Prassede;
    • Cicconi, Laura;
    • Santopietro, Michelina;
    • Gumenyuk, Svitlana;
    • Sarlo, Chiara;
    • Fenu, Susanna;
    • Tafuri, Agostino;
    • Latagliata, Roberto;
    • Fianchi, Luana;
    • Criscuolo, Marianna
    Publication type:
    Article
    12

    R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00723-4
    By:
    • Al-Sarayfi, Diana;
    • Meeuwes, Frederik O.;
    • Durmaz, Müjde;
    • Issa, Djamila E.;
    • Brouwer, Rolf E.;
    • Beeker, Aart;
    • van Rhenen, Anna;
    • Mutsaers, Pim G. N. J.;
    • Böhmer, Lara H.;
    • van der Poel, Marjolein W. M.;
    • te Boome, Liane;
    • van Meerten, Tom;
    • Chamuleau, Martine E. D.;
    • Zijlstra, Josée M.;
    • Brink, Mirian;
    • Nijland, Marcel
    Publication type:
    Article
    13
    14

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    15
    16

    Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00718-1
    By:
    • Balducci, Estelle;
    • Kaltenbach, Sophie;
    • Villarese, Patrick;
    • Duroyon, Eugénie;
    • Zalmai, Loria;
    • Friedrich, Chloé;
    • Suarez, Felipe;
    • Marcais, Ambroise;
    • Bouscary, Didier;
    • Decroocq, Justine;
    • Birsen, Rudy;
    • Fontenay, Michaëla;
    • Templé, Marie;
    • Brouzes, Chantal;
    • Touzart, Aurore;
    • Steimlé, Thomas;
    • Cieslak, Agata;
    • Lhermitte, Ludovic;
    • Almire, Carole;
    • Chapuis, Nicolas
    Publication type:
    Article
    17

    High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00717-2
    By:
    • Khwaja, Jahanzaib;
    • Bomsztyk, Joshua;
    • Mahmood, Shameem;
    • Wisniowski, Brendan;
    • Shah, Raakhee;
    • Tailor, Anish;
    • Yong, Kwee;
    • Popat, Rakesh;
    • Rabin, Neil;
    • Kyriakou, Charalampia;
    • Sive, Jonathan;
    • Esposti, Simona Degli;
    • Larkin, Daniel F. P.;
    • Worthington, Sarah;
    • Hart, Alyse;
    • Dowling, Emma;
    • Correia, Nuno;
    • Bygrave, Ceri;
    • Rydzewski, Andrzej;
    • Jamroziak, Krzysztof
    Publication type:
    Article